Welcome to LookChem.com Sign In|Join Free
  • or
Propanoic acid, 2-[2,6-dimethyl-4-[3-[4-(methylthio)phenyl]-3-oxo-1-propenyl]phenoxy]-2- methyl-, 1,1-dimethylethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

824932-90-3

Post Buying Request

824932-90-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

824932-90-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 824932-90-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,4,9,3 and 2 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 824932-90:
(8*8)+(7*2)+(6*4)+(5*9)+(4*3)+(3*2)+(2*9)+(1*0)=183
183 % 10 = 3
So 824932-90-3 is a valid CAS Registry Number.

824932-90-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[4-methylthiophenyl]-3-[3,5-dimethyl-4-(tert-butyloxycarbonyl-dimethylmethyl)oxyphenyl]prop-2-en-1-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:824932-90-3 SDS

824932-90-3Relevant academic research and scientific papers

PYRROLIDINE DERIVATIVES AS PPAR AGONISTS

-

Paragraph 0125; 0128; 0129, (2019/08/02)

The present invention discloses a class of pyrrolidine derivatives as PPAR agonist, and their use for the treatment of some diseases of PPAR receptor-associated pathways (such as nonalcoholic steatohepatitis and concurrent fibrosis, insulin resistance, primary biliary cholgangitis, dyslipidenmia, hyperlipidemia, hypercholesterolemia, atherosclerosis, hypertriglyceridemia, cardiovascular disease, obesity or the like). In particular, the present invention discloses a compound represented by Formula (I) or a pharmaceutically acceptable salt thereof.

GFT505 and preparation method for intermediate thereof

-

Paragraph 0041; 0042; 0043; 0044; 0045, (2017/08/29)

The invention discloses GFT505 and a preparation method for an intermediate thereof. The invention provides the preparation method for an intermediate I of GFT505, comprising the following steps: in an organic solvent, carrying out isomerization reaction

IMPROVED PREPARATION OF CHALCONE DERIVATIVES

-

Page/Page column 24-25, (2011/12/04)

The invention relates to methods for producing chalcone (1,3-diphenylprop-2-en-1 -one) derivatives that have multiple substitutions on a phenyl ring. Intermediate chalcone derivatives are modified by Phase Transfer Catalysis (PTC) for introducing a substi

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 824932-90-3